Scientists probe why Women's blood vessels change with age

NCT ID NCT06417177

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study looks at how aging and menopause change the way blood vessels widen in response to low oxygen. Researchers will give healthy women either a placebo, a beta-blocker (propranolol), or a bladder medication (gemtesa) to see how these drugs affect blood flow. The goal is to better understand the role of certain receptors in blood vessel function across different life stages.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Missouri-Columbia

    RECRUITING

    Columbia, Missouri, 65211, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Propranolol and Gemtesa (oral drugs) and placebo

What this could lead to

If successful, this could help scientists understand why blood vessels react differently to low oxygen as women age, potentially guiding future treatments for vascular health.

What could go wrong

This is an early-phase study with only 75 participants, so results may not apply to all women. The drugs used are for research purposes only and are not intended to treat any condition.

Conditions

The condition(s) this trial relates to.

Aneurysm Hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.